MIAS Pharma Limited, your European Partner, provides contract QP services to enable you to import and QP Release human medicinal products into Europe in a compliant manner with no significant investment in licence application, maintenance activities or office/personnel costs.
MIAS Pharma Limited holds two MIAs (Manufacturing and Importation Authorisations) to cover medicinal products for human use in EU/EEA:
1. MIA for Investigational Medicinal Products (IMPs)
The core service of MIAS Pharma is QP Batch Disposition. Whether you are carrying out a clinical trial in Europe or planning on Commercialising a product our MIAS QP’s can release your product in a compliant, time efficient and cost effective manner.
Entering the EU Market can be complex. MIAS will work with your Regulatory partner of choice to provide a QP declaration for your MAA (Marketing Authorisation Application) by validating that the API supply chain meets EMA GMP requirements.
Pharmaceutical supply chains often extend across multiple regulatory jurisdictions. MIAS can provide a dedicated QP resource to oversee the quality of the company’s supply chain and to deal with day-to-day quality-related issues arising.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.